# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015506
Filing Date
2021-11-10
Accepted
2021-11-10 16:21:31
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | olma-20210930x10q.htm iXBRL | 10-Q | 2029434
2 | EX-31.1 | olma-20210930xex31d1.htm | EX-31.1 | 12662
3 | EX-31.2 | olma-20210930xex31d2.htm | EX-31.2 | 12698
4 | EX-32 | olma-20210930xex32.htm | EX-32 | 10410
| Complete submission text file | 0001558370-21-015506.txt |  | 6724031

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | olma-20210930.xsd | EX-101.SCH | 40173
6 | EX-101.CAL | olma-20210930_cal.xml | EX-101.CAL | 45873
7 | EX-101.DEF | olma-20210930_def.xml | EX-101.DEF | 145812
8 | EX-101.LAB | olma-20210930_lab.xml | EX-101.LAB | 425750
9 | EX-101.PRE | olma-20210930_pre.xml | EX-101.PRE | 305097
10 | EXTRACTED XBRL INSTANCE DOCUMENT | olma-20210930x10q_htm.xml | XML | 1009423

Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 211396985
SIC: 2834 Pharmaceutical Preparations